STAT

STAT+: Lilly’s breast cancer combo wins approval

STAT+: Lilly’s breast cancer combo wins approvalWorldPing

The FDA just approved a new combination drug treatment for patients with an advanced form of breast cancer.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

More coverage: all health news on WorldPing.

Related news

ScienceDaily
WorldPing
ScienceDaily

This new drug could break cancer’s resistance to treatment

A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment.

Brief by WorldPing · Original reporting by ScienceDaily